While you take the necessary steps to keep safe during the Covid-19 pandemic, you should also pay close attention to your mental and emotional health. Associate Clinical Psychologist and Wellness Consultant Kamala McWhinney gives us tips to help cope with Covid-19.
With so much information swirling around Covid-19, we decided to ‘Get the Facts’ with Dr.Simone Spence, Director Health Promotion and Protection Branch, Ministry of Health and Wellness, Jamaica
What should people living with HIV know about Covid-19? Professor of Public Health, Epidemiology and HIV/AIDS at UWI Mona, Dr. Peter Figueroa, answers that question and many more.
What should people living with HIV know about Covid-19? Professor of Public Health, Epidemiology and HIV/AIDS at UWI Mona, Dr. Peter Figueroa, answers that question and many more.
With so much information swirling around Covid-19, we decided to ‘Get the Facts’ with Dr.Simone Spence, Director Health Promotion and Protection Branch, Ministry of Health and Wellness, Jamaica
While you take the necessary steps to keep safe during the Covid-19 pandemic, you should also pay close attention to your mental and emotional health. Associate Clinical Psychologist and Wellness Consultant Kamala McWhinney gives us tips to help cope with Covid-19.
There is currently no known difference between the clinical manifestations of COVID-19 or risk of severe illness or foetal compromise for pregnant and non-pregnant women or adults of reproductive age. Pregnant and recently pregnant women with suspected or confirmed COVID-19 should be treated with supportive and management therapies, considering the immunologic and physiologic adaptations during and after pregnancy which may overlap with COVID-19 symptoms. Data are limited but, until the evidence base provides clearer information, special consideration should be given to pregnant women with concomitant medical illnesses who could be infected with COVID-19. There are no reported deaths in pregnant women at time of publishing this information however, COVID-19 testing of symptomatic pregnant women may need to be prioritized to enable access to specialized care. All recently pregnant women with COVID-19 or who have recovered from COVID-19 should be provided with information and counselling on safe infant feeding and appropriate IPC measures to prevent COVID-19 virus transmission.
With confirmed disease or under investigation, management is similar to non-pregnant women, with appropriate isolation of confirmed or under investigation. Obstetric facilities must be notified and prepared, noting that each infant born to any mother with confirmed COVID-19 should be considered a ‘person under investigation’ and should be isolated according to the IPC guidance. Currently, it is unknown whether newborns with COVID-19 are at increased risk for severe complications.
It is important to assure continuous access to essential HIV prevention, testing and treatment services also where measurements of confinement are implemented within the public health response to the COVID-19 pandemic. While access to essential services should be maintained, adapted and evidence-based measures to reduce possible transmission should be considered and implemented. These include:
- Applying standard precautions for all patients (including ensuring that all patients cover their nose and mouth with a tissue or elbow when coughing or sneezing, offering a medical mask to patients with suspected COVID-19 infection while they are in waiting in the service, perform hand hygiene etc.)
- Health care and outreach workers, as well as peer educators and clients should apply adapted hand hygiene measures
- Ensuring triage, early recognition, and source control (isolating patients with suspected COVID-19 infection)
- Ensure there is adequate ventilation in all areas in the healthcare facility
- Spatial separation of at least 1 metre should ideally be maintained between all patients within all types of services
- Cleaning and disinfection procedures should be followed consistently and correctly
- Dispensing medicines (for treatment of HIV, TB and other chronic conditions such as opioid dependence) for longer periods allowing reduced frequency of patient visits
- Consider reduction of services to the most critical ones (provision of essential treatment and prevention services; services such as counselling sessions may be reduced or adapted)
Generally, vulnerable populations, including members of key populations, as well as homeless and/or displaced people may be at increased risk of infection – because of additional comorbidities impacting on their immune system, reduced ability to apply measures of confinement and social distancing, as well as generally limited access to health services. It is critical that services that reach these populations such as community-based services, drop-in centres and outreach services can continue providing life-saving prevention (distribution of condoms, needles and syringes), testing and treatment while securing safety of staff and clients. Services can be adapted according to above considerations where applicable.
People living with HIV with advanced disease, those with low CD4 and high viral load and those who are not taking antiretroviral treatment have an increased risk of infections and related complications in general. It is unknown if the immunosuppression of HIV will put a person at greater risk for COVID-19, thus, until more is known, additional precautions for all people with advanced HIV or poorly controlled HIV, should be employed.
At present there is no evidence that the risk of infection or complications of COVID-19 is different among people living with HIV who are clinically and immunologically stable on antiretroviral treatment when compared with the general population. Some people living with HIV may have known risk factors for COVID-19 complications, such as diabetes, hypertension and other noncommunicable diseases and as such may have increased risk of COVID-19 unrelated to HIV. We know that during the SARS and MERS outbreaks there were only a few case reports of mild disease among people living with HIV.
To date, there is a case report of a person living with HIV who had COVID-19 and recovered and a small study on risk factors and antiretrovirals used among people living with HIV with COVID-19 from China. This study reported similar rates of COVID-19 disease as compared to the entire population and increased risk with older age, but not with low CD4, high viral load level or antiretroviral regimen. Current clinical data suggest the main mortality risk factors are linked to older age and other comorbidities including cardiovascular disease, diabetes, chronic respiratory disease, and hypertension. Some very healthy people have also developed severe disease from the coronavirus infection.
PLHIV are advised to take the same precautions as the general population:
- wash hands often
- cough etiquette
- physical distancing
- seek medical care if symptomatic
- self-isolation if in contact with someone with COVID-19 and
- other actions per the government response
People living with HIV who are taking antiretroviral drugs should ensure that they have at least 30 days and up to 6-month supply of medicines and ensure that their vaccinations are up to date (influenza and pneumococcal vaccines). Adequate supplies of medicines to treat co-infections and comorbidities and addiction should also be ensured.
About 14,000 Jamaicans living with HIV
Name of Organisation | Website Link |
---|---|
International Treatment Preparedness Coalition (ITPC) | Visit Website |
Global Fund Advocates Network (GFAN) | Visit Website |
Global Fund Network of People Living with HIV (GNP+) | Visit Website |
MPact Global | Visit Website |
The Global Fund | Visit Website |
Global Network of Sex Work Projects | Visit Website |
While you take the necessary steps to keep safe during the Covid-19 pandemic, you should also pay close attention to your mental and emotional health. Associate Clinical Psychologist and Wellness Consultant Kamala McWhinney gives us tips to help cope with Covid-19.
With so much information swirling around Covid-19, we decided to ‘Get the Facts’ with Dr.Simone Spence, Director Health Promotion and Protection Branch, Ministry of Health and Wellness, Jamaica
What should people living with HIV know about Covid-19? Professor of Public Health, Epidemiology and HIV/AIDS at UWI Mona, Dr. Peter Figueroa, answers that question and many more.
What should people living with HIV know about Covid-19? Professor of Public Health, Epidemiology and HIV/AIDS at UWI Mona, Dr. Peter Figueroa, answers that question and many more.
With so much information swirling around Covid-19, we decided to ‘Get the Facts’ with Dr.Simone Spence, Director Health Promotion and Protection Branch, Ministry of Health and Wellness, Jamaica
While you take the necessary steps to keep safe during the Covid-19 pandemic, you should also pay close attention to your mental and emotional health. Associate Clinical Psychologist and Wellness Consultant Kamala McWhinney gives us tips to help cope with Covid-19.
There is currently no known difference between the clinical manifestations of COVID-19 or risk of severe illness or foetal compromise for pregnant and non-pregnant women or adults of reproductive age. Pregnant and recently pregnant women with suspected or confirmed COVID-19 should be treated with supportive and management therapies, considering the immunologic and physiologic adaptations during and after pregnancy which may overlap with COVID-19 symptoms. Data are limited but, until the evidence base provides clearer information, special consideration should be given to pregnant women with concomitant medical illnesses who could be infected with COVID-19. There are no reported deaths in pregnant women at time of publishing this information however, COVID-19 testing of symptomatic pregnant women may need to be prioritized to enable access to specialized care. All recently pregnant women with COVID-19 or who have recovered from COVID-19 should be provided with information and counselling on safe infant feeding and appropriate IPC measures to prevent COVID-19 virus transmission.
With confirmed disease or under investigation, management is similar to non-pregnant women, with appropriate isolation of confirmed or under investigation. Obstetric facilities must be notified and prepared, noting that each infant born to any mother with confirmed COVID-19 should be considered a ‘person under investigation’ and should be isolated according to the IPC guidance. Currently, it is unknown whether newborns with COVID-19 are at increased risk for severe complications.
It is important to assure continuous access to essential HIV prevention, testing and treatment services also where measurements of confinement are implemented within the public health response to the COVID-19 pandemic. While access to essential services should be maintained, adapted and evidence-based measures to reduce possible transmission should be considered and implemented. These include:
- Applying standard precautions for all patients (including ensuring that all patients cover their nose and mouth with a tissue or elbow when coughing or sneezing, offering a medical mask to patients with suspected COVID-19 infection while they are in waiting in the service, perform hand hygiene etc.)
- Health care and outreach workers, as well as peer educators and clients should apply adapted hand hygiene measures
- Ensuring triage, early recognition, and source control (isolating patients with suspected COVID-19 infection)
- Ensure there is adequate ventilation in all areas in the healthcare facility
- Spatial separation of at least 1 metre should ideally be maintained between all patients within all types of services
- Cleaning and disinfection procedures should be followed consistently and correctly
- Dispensing medicines (for treatment of HIV, TB and other chronic conditions such as opioid dependence) for longer periods allowing reduced frequency of patient visits
- Consider reduction of services to the most critical ones (provision of essential treatment and prevention services; services such as counselling sessions may be reduced or adapted)
Generally, vulnerable populations, including members of key populations, as well as homeless and/or displaced people may be at increased risk of infection – because of additional comorbidities impacting on their immune system, reduced ability to apply measures of confinement and social distancing, as well as generally limited access to health services. It is critical that services that reach these populations such as community-based services, drop-in centres and outreach services can continue providing life-saving prevention (distribution of condoms, needles and syringes), testing and treatment while securing safety of staff and clients. Services can be adapted according to above considerations where applicable.
People living with HIV with advanced disease, those with low CD4 and high viral load and those who are not taking antiretroviral treatment have an increased risk of infections and related complications in general. It is unknown if the immunosuppression of HIV will put a person at greater risk for COVID-19, thus, until more is known, additional precautions for all people with advanced HIV or poorly controlled HIV, should be employed.
At present there is no evidence that the risk of infection or complications of COVID-19 is different among people living with HIV who are clinically and immunologically stable on antiretroviral treatment when compared with the general population. Some people living with HIV may have known risk factors for COVID-19 complications, such as diabetes, hypertension and other noncommunicable diseases and as such may have increased risk of COVID-19 unrelated to HIV. We know that during the SARS and MERS outbreaks there were only a few case reports of mild disease among people living with HIV.
To date, there is a case report of a person living with HIV who had COVID-19 and recovered and a small study on risk factors and antiretrovirals used among people living with HIV with COVID-19 from China. This study reported similar rates of COVID-19 disease as compared to the entire population and increased risk with older age, but not with low CD4, high viral load level or antiretroviral regimen. Current clinical data suggest the main mortality risk factors are linked to older age and other comorbidities including cardiovascular disease, diabetes, chronic respiratory disease, and hypertension. Some very healthy people have also developed severe disease from the coronavirus infection.
PLHIV are advised to take the same precautions as the general population:
- wash hands often
- cough etiquette
- physical distancing
- seek medical care if symptomatic
- self-isolation if in contact with someone with COVID-19 and
- other actions per the government response
People living with HIV who are taking antiretroviral drugs should ensure that they have at least 30 days and up to 6-month supply of medicines and ensure that their vaccinations are up to date (influenza and pneumococcal vaccines). Adequate supplies of medicines to treat co-infections and comorbidities and addiction should also be ensured.
Name of Organisation | Website Link |
---|---|
International Treatment Preparedness Coalition (ITPC) | http://itpcglobal.org/covid-19/ |
Global Fund Advocates Network (GFAN) | https://www.globalfundadvocatesnetwork.org/?s=COVID |
Global Fund Network of People Living with HIV (GNP+) | https://gnpplus.net/project/covid-19-and-people-living-with-hiv/ |
MPact Global | https://mpactglobal.org/?s=COVID |
The Global Fund | https://www.theglobalfund.org/en/covid-19/ |
Global Network of Sex Work Projects | https://www.nswp.org/search?site_search=COVID |